Step Pharma Funding: $146M Raised, Series C (2023)
Step Pharma is based in Paris, France. It has raised $146M in total funding. Latest round: Series C.
Step Pharma funding overview
Step Pharma is based in Paris, France. Step Pharma has raised $146M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2023. The round record for Step Pharma runs through 2023; nothing later has been disclosed. Investors on record include V-Bio Ventures, Pontifax Venture Capital, Bpifrance, Kurma Partners, Hadean Ventures, Sunstone Life Science Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Step Pharma has raised $146M in total disclosed funding across the rounds on record.
Who has invested in Step Pharma?
V-Bio Ventures, Pontifax Venture Capital, Bpifrance, Kurma Partners, Hadean Ventures, Sunstone Life Science Ventures are named among the investors backing Step Pharma.
What was the latest Step Pharma funding round?
The most recent disclosed round is a Series C, announced in October 2023.
Where is Step Pharma based?
Step Pharma is based in Paris, France.
When did Step Pharma last raise?
The last disclosed Step Pharma round closed in October 2023 at Series C.
Step Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Paris below to benchmark round size and investor mix.
